The integrity of the antimicrobial supply chain in Bangladesh: assessing the regulatory environment and contextual challenges.

ABSTRACT: Most low- and middle-income countries lack the regulatory capacity to contain substandard and falsified (SF) medicines. Innovations for strengthening regulatory systems are needed to protect public health. We assessed the integrity of the antimicrobial supply chain in Bangladesh. We employed qualitative methods comprising policy content analysis, and literature and database reviews. Using a framework modified from the World Health Organization's and the United States Pharmacopoeia's, the Bangladesh National Drug Policy (BNDP), was evaluated for provisions on medicines quality assurance mechanisms. We used newspaper, peer-reviewed, and post-marketing surveillance reports to assess prevalence of SF antimicrobials. The BNDP contains provisions for quality assurance. Newspaper reports identifi

SUBMITTER: Orubu ESF 

PROVIDER: S-EPMC9646268 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature